Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
Clinical trial NCT03959293 · UNKNOWN
Trial details
- NCT number
- NCT03959293
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2022-03-15
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.